Prescription of drugs not appropriate for children in a Pediatric Intensive Care Unit;Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo pediátrica

Jornal de Pediatria

Volumn 79, Issue 5, 2003, Pages 397-402

  Carvalho, Paulo R A ^a   Carvalho, Clarissa G ^a   Alievi, Patrícia T ^a   Martinbiancho, Jaqueline ^a   Trotta, Eliana A ^a  

^a NONE

Author keywords

Children; Drugs; Intensive care; Not approved prescribing; Off label prescribing

Indexed keywords

CEFEPIME; CHLORAL HYDRATE; DIAZEPAM; DIPYRONE; DOPAMINE; FENTANYL; FUROSEMIDE; GLUCONATE CALCIUM; HYDROCORTISONE; KETAMINE; METOCLOPRAMIDE; MIDAZOLAM; MINERAL OIL; OMEPRAZOLE; ONDANSETRON; PARACETAMOL; PHENYTOIN; POTASSIUM CHLORIDE; RANITIDINE; SALBUTAMOL; SULTAMICILLIN; VANCOMYCIN;

ADOLESCENT; ARTICLE; BRAZIL; CHILD; DRUG APPROVAL; DRUG INDICATION; DRUG MISUSE; FOOD AND DRUG ADMINISTRATION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OFF LABEL PRESCRIPTION; PRESCRIPTION; PREVALENCE; RESPIRATORY TRACT DISEASE;

EID: 0242713059     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1069     Document Type: Article

References (22)

1. Kauffman RE. Essential drugs for infants and children: North American perspective. Pediatrics 1999;104(3 Pt 2):603-5.
2. Jong GW, Vulto AG, de Hoog M, Schimmel KJM, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch Children's Hospital. Pediatrics 2001;108: 1089-93.
3. Thompson DF, Heflin NR. Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients. Am J Hosp Pharm 1987;44:792-6.
4. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
5. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998;316:343-5.
6. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999;88:965-8.
7. Chalumeau M, Tréluyer M, Salanave B, Assathiany R, Chéron G, Crocheton N, et al. Off label and unlicensed drug use among French office based pediatricians. Arch Dis Child 2000;83:502-5.
8. Gavrilov V, Lifshitz M, Levy J, Gorodischer R. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2000;2:595-7.
9. AAP: Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 1995;95:286-344.
10. Meiners MMMA, Bergsten-Mendes G. Prescrição de medicamentos para crianças hospitalizadas: como avaliar a qualidade? Rev Assoc Med Bras 2001;47:332-7.
11. Christensen ML, Helms RA, Chesney RW. Is pediatric labeling really necessary? Pediatrics 1999;104(3 Pt 2):593-7.
12. Wilson JT. An update on the therapeutic orphan. Pediatrics 1999;104(3 Pt 2):585-90.
13. Shann F, Pearson G, Slater A, Wilkinson K. Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 1997;23:201-7.
14. a ed. Rockville: United States Pharmacopeial Convention; 2001. vol. 1.
15. Agência Nacional de Vigilância Sanitária [site na Internet]. Disponível: www.anvisa.gov.br. Acessado: 24 de maio de 2003.
16. Autret E. European regulatory authorities and pediatric labeling. Pediatrics 1999;104(3 Pt 2):614-8.
17. Turner S, Gill AM, Nunn AJ, Hewitt B, Choonara I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet 1996;347:549-50.
18. Gill AM, Leach HJ, Hughes J, Barker C, Nunn AJ, Choonara I. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr 1995;84:438-41.
19. Blumer JL. Off-label uses of drugs in children. Pediatrics 1999;104:598-602.
20. American Academy of Pediatrics. Committee on Drugs. Pediatrics 2002;110:181-3.
21. Cohen SN. The pediatric Pharmacology research unit network and its role in meeting pediatric labeling needs. Pediatrics 1999;104:644-5.
22. Kmictowicz Z. Drug industry is unwilling to run trials in children. BMJ 2000;320:1362.